RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jin Yang Pharmaceutical Co Stock

Jin Yang Pharmaceutical Co Equity 2024

Jin Yang Pharmaceutical Co Equity

89.58 B KRW

Ticker

007370.KQ

ISIN

KR7007370000

In 2024, Jin Yang Pharmaceutical Co's equity was 89.58 B KRW, a 15.48% increase from the 77.58 B KRW equity in the previous year.

Jin Yang Pharmaceutical Co Aktienanalyse

What does Jin Yang Pharmaceutical Co do?

Jin Yang Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Jin Yang Pharmaceutical Co's Equity

Jin Yang Pharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Jin Yang Pharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Jin Yang Pharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Jin Yang Pharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Jin Yang Pharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Jin Yang Pharmaceutical Co stock

What is the equity of Jin Yang Pharmaceutical Co this year?

Jin Yang Pharmaceutical Co has equity of 89.58 B KRW this year.

What was the equity of Jin Yang Pharmaceutical Co compared to the previous year?

The equity of Jin Yang Pharmaceutical Co has increased/decreased by 15.48% increased compared to the previous year.

What impact does a high equity have on investors of Jin Yang Pharmaceutical Co?

A high equity is advantageous for investors of Jin Yang Pharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Jin Yang Pharmaceutical Co?

A low equity can be a risk for investors of Jin Yang Pharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Jin Yang Pharmaceutical Co affect the company?

An increase in equity of Jin Yang Pharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Jin Yang Pharmaceutical Co affect the company?

A reduction in equity of Jin Yang Pharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Jin Yang Pharmaceutical Co?

Some factors that can affect the equity of Jin Yang Pharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Jin Yang Pharmaceutical Co so important for investors?

The equity of Jin Yang Pharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Jin Yang Pharmaceutical Co take to change the equity?

To change equity, Jin Yang Pharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Jin Yang Pharmaceutical Co pay?

Over the past 12 months, Jin Yang Pharmaceutical Co paid a dividend of 150 KRW . This corresponds to a dividend yield of about 2.79 %. For the coming 12 months, Jin Yang Pharmaceutical Co is expected to pay a dividend of 150 KRW.

What is the dividend yield of Jin Yang Pharmaceutical Co?

The current dividend yield of Jin Yang Pharmaceutical Co is 2.79 %.

When does Jin Yang Pharmaceutical Co pay dividends?

Jin Yang Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Jin Yang Pharmaceutical Co?

Jin Yang Pharmaceutical Co paid dividends every year for the past 20 years.

What is the dividend of Jin Yang Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 150 KRW are expected. This corresponds to a dividend yield of 2.79 %.

In which sector is Jin Yang Pharmaceutical Co located?

Jin Yang Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jin Yang Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jin Yang Pharmaceutical Co from 3/1/2024 amounting to 150 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.

When did Jin Yang Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 3/1/2024.

What was the dividend of Jin Yang Pharmaceutical Co in the year 2023?

In the year 2023, Jin Yang Pharmaceutical Co distributed 150 KRW as dividends.

In which currency does Jin Yang Pharmaceutical Co pay out the dividend?

The dividends of Jin Yang Pharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Jin Yang Pharmaceutical Co

Our stock analysis for Jin Yang Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jin Yang Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.